• Reptilase® Clotting Time
  • Schistosoma, Antibody, IgG
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Factor XIII (F13A1) V34L Genetic Variation Analysis
  • Centromere Antibody, IgG
  • SARS-CoV-2 (COVID-19) Coronavirus, Genotyping
  • Serine and Arginine-rich Splicing Factor 2 (SRSF2) Gene Mutation Analysis
  • Estradiol Free, Serum
  • Bacterial Vaginosis Pathogens by Molecular Method
  • Culture, Throat
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Pleural Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Pleural Fluid
Medical Test

Interpretation
Access to Cancer Antigen (CA) 19-9, Pleural Fluid is restricted.